NEUROPACE, INC. Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax
NEUROPACE, INC. (NPCE) had Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax of $0 as of 2026-03-31, per its 10-Q filed 2026-05-12.
Financial Statements › Notes › Debt Securities, Available-for-Sale, Fair Value to Amortized Cost, after Allowance for Credit Loss
us-gaap:AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax · last filed 2026-08-11
- 2026-03-31: Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax $0.00.
- 2025-12-31: Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax $200.00K.
- 2025-09-30: Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax $200.00K.
- 2025-06-30: Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax $100.00K.
| Period end | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax |
|---|---|
| 2026-03-31 | $0.00 10-Q · filed 2026-05-12 |
| 2025-12-31 | $200.00K 10-Q · filed 2026-08-11 |
| 2025-09-30 | $200.00K 10-Q · filed 2025-11-04 |
| 2025-06-30 | $100.00K 10-Q · filed 2025-08-12 |
| 2025-03-31 | $100.00K 10-Q · filed 2025-05-13 |
| 2024-12-31 | $100.00K 10-K · filed 2026-03-03 |
| 2024-09-30 | $200.00K 10-Q · filed 2024-11-12 |
| 2021-09-30 | $33.00K 10-Q · filed 2021-11-10 |
| 2021-06-30 | $11.00K 10-Q · filed 2021-08-12 |
| 2021-03-31 | $33.00K 10-Q · filed 2021-06-03 |
| 2020-12-31 | $33.00K 10-Q · filed 2021-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Sight Sciences, Inc. (SGHT) | United States | $0.478B | -9.95 |
| ClearPoint Neuro, Inc. (CLPT) | United States | $0.446B | -15.74 |
| TACTILE SYSTEMS TECHNOLOGY INC (TCMD) | United States | $0.519B | 27.16 |
| CERUS CORP (CERS) | United States | $0.525B | -86.40 |
| CARLSMED, INC. (CARL) | United States | $0.405B | |
| DELCATH SYSTEMS, INC. (DCTH) | United States | $0.558B | 820.33 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| SS Innovations International, Inc. (SSII) | $0.589B | -64.06 | |
| ORTHOPEDIATRICS CORP (KIDS) | United States | $0.592B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |